Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $1.00 per share
-
Shares outstanding
-
7.36M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3.16M
-
Shares change
-
+814K
-
Total reported value, excl. options
-
$35.2M
-
Value change
-
+$9.03M
-
Number of buys
-
28
-
Number of sells
-
-6
-
Price
-
$11.15
Significant Holders of HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) as of Q3 2022
37 filings reported holding HHS - HARTE HANKS INC - Common Stock, par value $1.00 per share as of Q3 2022.
HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.16M shares
of 7.36M outstanding shares and own 42.91% of the company stock.
Largest 10 shareholders include WESTERLY CAPITAL MANAGEMENT, LLC (670K shares), BLAIR WILLIAM & CO/IL (661K shares), Hillsdale Investment Management Inc. (337K shares), RENAISSANCE TECHNOLOGIES LLC (181K shares), VANGUARD GROUP INC (173K shares), ACADIAN ASSET MANAGEMENT LLC (135K shares), EAM Investors, LLC (132K shares), CREDIT SUISSE AG/ (129K shares), TWO SIGMA INVESTMENTS, LP (83.6K shares), and Eidelman Virant Capital (70.5K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.